The planned sales comprise up to 13.2 million shares of Jubilant FoodWorks, 12 million shares of Jubilant Ingrevia, and 5.6 million shares of Jubilant Pharmova, sources told CNBC-TV18.
Jubilant FoodWorks operates popular quick-service restaurant chains like Domino’s Pizza and Dunkin’ in India. Jubilant Ingrevia specializes in life science ingredients and chemicals, while Jubilant Pharmova focuses on pharmaceuticals and contract research services.
Also Read: Jubilant FoodWorks’ three-year strategy: Korean buns, cheese tarts, and a grand pizza!
Positive Q4
Jubilant FoodWorks announced a remarkable 93% year-on-year (YoY) increase in standalone net profit, reaching ₹49.5 crore for the fourth quarter ending March 31, 2025. In the same quarter of the previous fiscal year, it recorded a net profit of ₹25.6 crore.
The CNBC-TV18 survey had anticipated a profit of ₹32 crore for Q4. The company’s standalone revenue from operations rose 19.1% to ₹1,587 crore, compared to ₹1,332.3 crore in the same period of the preceding fiscal.
Jubilant Ingrevia saw its consolidated net profit more than double to ₹74.05 crore in the March 2025 quarter, driven by lower expenses. Its net profit was ₹29.25 crore a year ago. However, the total income for Q4 decreased to ₹1,059.62 crore from ₹1,083.94 crore last year.
Also Read: Three essential factors for Jubilant FoodWorks to achieve a $10 billion market cap by FY30
The increase in net profit was primarily due to a reduction in total expenses to ₹957.87 crore from ₹1,032.54 crore. During the FY25 fiscal year, net profit rose to ₹251.17 crore, compared to ₹182.89 crore in the previous fiscal.
Shares of Jubilant FoodWorks Ltd closed at ₹665.75 on the BSE, declining by ₹20.10, or 2.93%, while Jubilant Ingrevia Ltd finished at ₹683.45, up by ₹4.80, or 0.71%. Jubilant Pharmova Ltd settled at ₹1,125, down ₹19.90, or 1.74%.
(Edited by : Shoma Bhattacharjee)
First Published: Jun 12, 2025 6:48 PM IST
